Cue Biopharma, Inc. - Special Call Transcript
Greetings, and welcome to the Cue Biopharma Third Quarter 2019 Earnings Call. (Operator Instructions) As a reminder, this conference is being recorded.
It is now my pleasure to introduce your host, Mr. Joshua Drumm, Investor Relations. Thank you. You may begin.
Thanks, Michelle. Good afternoon, everyone. This is Josh Drumm from Life Sci Advisors. Thank you for joining us on today's investor and analyst update call.
Joining me on the call today are Dan Passeri, Cue Biopharma's CEO; Dr. Anish Suri, President and Chief Scientific Officer; Dr. Ken Pienta, acting Chief Medical Officer; and Kerri-Ann Millar, VP of Finance and Principle Accounting and Finance Officer.
Before we begin, I would like to remind you that during today's call, the company will be making forward-looking statements. Various remarks that the company makes during this call about the company's future expectations, plans and prospects constitute forward-looking statements for purposes of the Private Securities
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
